References
- Fushimi T, Takei Y, Touma T, Kudoh S, Yamamoto K, Hoshii Y, Ishihara T, et al. Bilateral localized amyloidosis of the ureters: clinicopathology and therapeutic approaches in two cases. Amyloid 2004;11:260–4
- Mattocks S, Molyneux AJ, Doyle P. Localized amyloidosis of the prostate. Br J Urol 1993;72:655–6
- Palladini G, Perfetti V, Obici L, Caccialanza R, Semino A, Adami F, Cavallero G, et al. Association of melphalan and high-dose dexamethazone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation. Blood 2004;103:2936–8
- Palladini G, Dispenzieri A, Gertz MA, Kumar S, Wechalekar A, Hawkins PN, Schönland S, et al. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes. J Clin Oncol 2012;30:4541–9
- Kyle RA, Gertz MA. Primary systemic amyloidosis. Clinical and laboratory features in 474 Cases. Semin Hematol 1995;32:45–59
- Paccalin M, Hachulla E, Cazalet C, Tricot L, Carreiro M, Rubi M, Grateau G, et al. Localized amyloidosis: a survey of 35 French cases. Amyloid 2005;12:239–45
- Miura K, Shirasawa H. Lambda III subgroup immunoglobulin light chains are precursor proteins of nodular pulmonary amyloidosis. Am J Clin Pathol 1993;100:561–6
- Fischer B, Palkovic S, Rickert C, Weckesser M, Wassmann H. Cerebral AL λ-amyloidoma: clinical and pathomorphological characteristics. Review of the literature and of a patient. Amyloid 2007;14:11–19
- Snyder ME, Haidar GR, Spencer B, Maurer MS. Transthyretin cardiac amyloidosis diagnosed by analyzing a prostatic tissue sample: a case report. J Am Geriatr Soc 2011;59:1745–7
- Hoshii Y, Seguchi M, Iwata T, Ueda J, Cui D, Kawano H, Gondo H, et al. Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis. Pathol Int 2001;51:264–70